K
Keith Sudheimer
Researcher at Stanford University
Publications - 37
Citations - 3145
Keith Sudheimer is an academic researcher from Stanford University. The author has contributed to research in topics: Brain stimulation & Default mode network. The author has an hindex of 17, co-authored 34 publications receiving 2360 citations. Previous affiliations of Keith Sudheimer include Palo Alto University & University of Michigan.
Papers
More filters
Journal ArticleDOI
Resting-state connectivity biomarkers define neurophysiological subtypes of depression
Andrew T. Drysdale,Logan Grosenick,Logan Grosenick,Jonathan Downar,Katharine Dunlop,Farrokh Mansouri,Yue Meng,Robert N. Fetcho,Benjamin D. Zebley,Desmond J. Oathes,Amit Etkin,Alan F. Schatzberg,Keith Sudheimer,Jennifer Keller,Helen S. Mayberg,Faith M. Gunning,George S. Alexopoulos,Michael D. Fox,Alvaro Pascual-Leone,Henning U. Voss,B. J. Casey,Marc J. Dubin,Conor Liston +22 more
TL;DR: It is shown here that patients with depression can be subdivided into four neurophysiological subtypes defined by distinct patterns of dysfunctional connectivity in limbic and frontostriatal networks, which may be useful for identifying the individuals who are most likely to benefit from targeted neurostimulation therapies.
Journal ArticleDOI
Facial expressions and complex IAPS pictures: common and differential networks.
TL;DR: In this article, the authors compared BOLD activation patterns to facial expression of emotions and to complex emotional pictures from the International Affective Picture System (IAPS) to determine if these stimuli would activate similar or distinct brain regions.
Journal ArticleDOI
Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism.
Nolan R. Williams,Boris D. Heifets,Christine Blasey,Keith Sudheimer,Jaspreet Pannu,Heather Pankow,Jessica Hawkins,Justin Birnbaum,David M. Lyons,Carolyn I. Rodriguez,Alan F. Schatzberg +10 more
TL;DR: The findings suggest that ketamine's acute antidepressant effect requires opioid system activation, and the dissociative effects of ketamine are not mediated by the opioid system, and they do not appear sufficient without the opioid effect to produce the acute antidepressant effects ofketamine in adults with treatment-resistant depression.
Posted ContentDOI
Stanford Accelerated Intelligent Neuromodulation Therapy for Treatment-Resistant Depression (SAINT-TRD)
E. Cole,Katy H. Stimpson,M. Gulser,Kirsten Cherian,Claudia Tischler,Romina Nejad,Brandon S. Bentzley,Heather Pankow,Elizabeth Choi,Haley Aaron,Flint M. Espil,Jaspreet Pannu,Xiaoqian Xiao,Dalton Duvio,Hugh B. Solvason,Jessica Hawkins,Jennifer Keller,Alan F. Schatzberg,Keith Sudheimer,Nolan R. Williams +19 more
TL;DR: The authors' accelerated, high-dose, iTBS protocol with fcMRI-guided targeting (SAINT) was well tolerated and safe, especially for this treatment-resistant population, and effectiveness was strikingly high.
Journal ArticleDOI
High-dose spaced theta-burst TMS as a rapid-acting antidepressant in highly refractory depression
Nolan R. Williams,Keith Sudheimer,Brandon S. Bentzley,Jaspreet Pannu,Katy H. Stimpson,Dalton Duvio,Kirsten Cherian,Jessica Hawkins,Kristen Hymel Scherrer,Benjamin Vyssoki,Danielle D. DeSouza,Kristin S. Raj,Jennifer Keller,Alan F. Schatzberg +13 more